This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Zicronapine

H. Lundbeck A/S

Drug Names(s): Lu 31-130

Description: Lu 31-130 is an atypical psychotic with antagonistic effects at dopamine D1, D2 and 5-HT2a receptors. Although published data are limited, Lundbeck has stated that the compound exhibits selectivity for D1 over D2 receptors in the prefrontal cortex. The company believes that this selectivity profile will be associated with cognition enhancement and relatively modest EPS and metabolic side effects.


Zicronapine News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug